/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-03-07-18-18-17-684-67cb3869e563d7057cd672ff.jpg)
In an attempt to facilitate capital raising, the SEC announced that it was expanding the ability of issuers to submit draft registration...
What's Trending
Tracking trends critical to life sciences and technology companies.
/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-02-27-19-26-00-987-67c0bc482037da0c91784a25.jpg)
Life sciences M&A comes with unique challenges that require thoughtful and creative structuring. Bridging valuation gaps between buyers...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-02-11-22-25-35-838-67abce5fc56e29c3df633347.jpg)
Various biotech companies have completed or launched their IPOs so far in 2025. As of early February, five sizeable life sciences...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-01-17-19-47-25-859-678ab3cdd475f5436589df95.jpg)
Stanford Business recently posted an interesting article describing the results of a three-year study conducted to analyze American...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-01-07-00-23-12-967-677c73f0fb5a0d2e249de5e4.jpg)
The following new disclosure will be required in companies’ upcoming Forms 10-K (FY 2024) and/or proxy statements: Upcoming Disclosure...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2025-01-06-23-09-46-920-677c62ba856ebaca6a9b9b0d.jpg)
As we start the new year, many public companies are in the middle of preparing their annual reports on Form 10-K and registration...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-12-20-19-15-23-892-6765c24b56703740369429eb.jpg)
The United States is facing another potential government shutdown going into this weekend. In such an event, the Division of Corporate...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-12-18-03-19-34-406-67623f46d656807b246e4e39.jpg)
On December 17, the U.S. Securities and Exchange Commission announced it settled charges against fashion retailer Express, Inc. for...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-12-18-00-41-31-003-67621a3b5e19b3282e8e407c.jpg)
The U.S. Securities and Exchange Commission (SEC) recently published its Fall 2024 Reg-Flex Agenda. The SEC updated the anticipated...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-12-03-18-45-51-992-674f51dfe849f6c181f55c11.jpg)
On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-11-26-23-44-39-966-67465d672f6dbf608478c251.jpg)
Beginning December 18, Schedules 13D and 13G must be filed using an XML-based language. Filers will have the option of (1) using a...
/Passle/660d68b6653e644c49237200/SearchServiceImages/2024-09-20-20-12-36-267-66edd734d3255dfed911c637.jpg)
On September 13, the SEC charged Zymergen Inc., a biotechnology company, with misleading IPO investors about the company’s market...